Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year
Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space.
Stock market today: US futures wobble as Wall Street looks to end volatile week on high note
Donald Trump wants a 'say' in setting interest rates
What to do after a week of stock turmoil? Strategists say do nothing: Morning Brief
Disney Stock: Bull vs. Bear
This leading media and entertainment enterprise has valid arguments on both sides of the aisle.
Stocks Rebound as Jobs Data Calms Market Jitters: Markets Wrap
(Bloomberg) -- Asian equities were poised for gains on Friday after signs of resilience in the labor market lifted US stocks.Most Read from BloombergAfrica’s Richest City Needs $12 Billion to Fix InfrastructureHow a Tiny Midwestern Town Became a Mecca for Modern ArchitectureNYC Subway Riders See ‘Exceptionally High’ Air PollutionNew York City Paid $2 Million for Empty Hotel Rooms Meant for MigrantsNew York City’s Outdoor Dining Sheds Will Start DisappearingEquity futures for Japan, Australia and
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're not advertising," Eli Lilly CEO David Ricks said.
Paramount reports first quarter of streaming profits, plans 15% layoff and takes $6 billion charge on cable business
Nvidia stock surges 6% as chip stocks lead market rebound
Dine Brands CEO: Restaurants are in a 'value war' as consumers tighten their belts